Alt image -https://content.stockstotrade.com/wp-content/uploads/2025/12/bullish-stock-market-trends-13.png

MakeMyTrip Soars as CICC Cuts in with Outperform Rating

TIM BOHEN•UPDATED DEC. 13, 2025, 11:42 AM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

MakeMyTrip Limited stock surges 5.21% amid investor optimism following strategic market expansion and anticipated travel industry recovery.

Market Insights: An Inflection Point for MMYT

  • CICC has launched coverage of MakeMyTrip, giving it an “Outperform” rating paired with a $95 price target, boosting investor confidence.
  • This move signals CICC’s confidence in MakeMyTrip’s strategic growth opportunities and market potential in the online travel industry.
  • MakeMyTrip’s strong financial foundation contributes to rising expectations for its future performance and competitive advantage.

Consumer Discretionary industry expert:

Analyst sentiment – positive

MakeMyTrip (MMYT) holds a challenging market position, reflected in its substantial enterprise value of $8.67 billion and a significant price-to-sales ratio of 8.93. The company’s profitability metrics present a complex picture, with a negative pretax profit margin of -11.8%, suggesting considerable margin pressure. While revenue stands at $978.34 million, the consecutive revenue declines over three and five years signal systemic weaknesses. Financial strength indicators highlight a low long-term debt-to-capital ratio of 0.01 and leverage ratio of 1.5, underlining moderate debt exposure. The negative returns on equity and assets accentuate operational inefficiencies.

Weekly price analysis reveals a consistent uptrend for MMYT, with price levels moving from $69.85 to $82.60. The sharp, linear price movements support a bullish sentiment. There is an absence of price volatility, indicating a steady accumulation phase. Traders should consider a buy strategy, leveraging the breakout above $78.51 as a confirmation. Consolidation above this level, combined with increased volume, could materialize a strong support level. Continued price escalation above $82.60 could signal further upside potential, aligning well with technical indicators.

The outlook for MakeMyTrip aligns positively with catalysts such as CICC’s initiation of coverage with an “Outperform” rating and a $95 price target. This bullish analyst perspective supports market optimism and suggests considerable upside potential. Comparative analysis with Consumer Discretionary and Hotels, Lodging & Leisure benchmarks hints at MMYT’s relatively strong momentum. Key support is grounded at the $78.00 range, with resistance potentially emerging as the price approaches the projected target of $95. Overall, the alignment of analyst ratings and technical strength projects an optimistic trajectory.

Candlestick Chart

Get Free Alerts

More Breaking News

Weekly Update Dec 08 – Dec 12, 2025: On Saturday, December 13, 2025 MakeMyTrip Limited stock [NASDAQ: MMYT] is trending up by 5.21%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

In a quick financial snapshot, MakeMyTrip displays a robust financial position despite a recent trend of fluctuating stock prices. The company, with a revenue of $978.34M, showcases a diversified revenue stream and a wide reach within the travel industry. The data reflects a highly leveraged position, with a debt-to-equity ratio indicating efficient capital management amid growth initiatives.

The MakeMyTrip stock has taken an upward trajectory in recent days, growing steadily with a monthly high pull towards $82.6 set against a backdrop of fluctuating daily trade volumes. These movements hint at growing market confidence and anticipated earnings strength. Historical data suggest progressive investor optimism, which aligns with strategic moves by the company to solidify its market hold.

Key performance ratios, though reflecting a few negative readings such as the pretax profit margin at -11.8, indicate areas for improvement. Yet, strategic positioning and external validations like CICC’s coverage uplift the firm’s potential to stabilize and capitalize on growth projections. Current assets well over $1B bolster its resilience amidst industry challenges and regulatory pressures.

Conclusion

The introduction of an “Outperform” rating by CICC ignites a positive shift for MakeMyTrip, bolstering market perceptions of its value proposition. Coupled with strong fundamental indicators, the forecast sets a promising horizon for potential stock appreciation. In light of this, traders may observe gains as MakeMyTrip leverages market dynamics to enhance its competitive foothold. As Tim Bohen, lead trainer with StocksToTrade says, “I focus on what a stock is doing, not what I want it to do. Let the stock prove itself before you make a move.” This reinforces the idea that traders should carefully watch MakeMyTrip’s actual performance amidst the unfolding narrative of market positioning. Consequently, MakeMyTrip emerges as a resilient player ready to navigate growth with strategic foresight and robust market engagement.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders